Antibiotic Treatment for Bacterial Bronchitis
For acute bronchitis in otherwise healthy adults, antibiotics should NOT be prescribed as this is primarily a viral illness with no proven benefit from antibiotic therapy. 1, 2
When Antibiotics Are NOT Indicated
- Acute bronchitis in healthy adults: Routine antibiotic treatment is not justified and should not be offered, as acute bronchitis is primarily viral in origin 1, 2
- Simple chronic bronchitis exacerbations: Immediate antibiotic therapy is not recommended, even if fever is present 1
- Purulent or discolored sputum (green/yellow) does NOT indicate bacterial infection and is not an indication for antibiotics 2
When Antibiotics ARE Indicated
Antibiotics should be prescribed in the following specific scenarios:
1. Chronic Obstructive Bronchitis with Anthonisen Criteria
- Prescribe antibiotics when at least 2 of 3 Anthonisen criteria are present: increased sputum volume, increased sputum purulence, and increased dyspnea 1, 2
- This applies to patients with FEV1 between 35% and 80% 2
2. Chronic Respiratory Insufficiency
- Immediate antibiotic therapy is recommended for patients with FEV1 <35% and hypoxemia at rest during exacerbations 1, 2
3. Persistent Fever
- Consider antibiotics if fever >38°C persists for more than 3 days, suggesting bacterial superinfection or pneumonia 1, 2
4. Confirmed Pertussis (Whooping Cough)
- A macrolide antibiotic is necessary for confirmed or suspected pertussis, with patient isolation for 5 days from treatment start 1
First-Line Antibiotic Recommendations
For bacterial bronchitis requiring treatment, amoxicillin is the preferred first-line agent. 2
- Amoxicillin: First-line choice for suspected bacterial bronchitis 2
- Azithromycin: Alternative first-line option, particularly effective with 500 mg once daily for 3 days 2, 3
- Doxycycline or other macrolides: For patients with penicillin allergy 2
Second-Line Antibiotic Options
If first-line therapy fails, use amoxicillin-clavulanate as the reference second-line therapy. 2
- Amoxicillin-clavulanate: 625 mg three times daily for 7-10 days 1, 2
- Second or third-generation cephalosporins: Cefuroxime-axetil, cefpodoxime-proxetil (8 mg/kg/day in two doses), or cefotiam-hexetil 1, 2
- Respiratory fluoroquinolones: Levofloxacin or moxifloxacin (NOT ciprofloxacin or ofloxacin, which lack adequate pneumococcal coverage) 2, 6
Target Pathogens
Antibiotic selection must cover the three primary bacterial pathogens:
Treatment Duration
- Azithromycin: 3-5 days (500 mg day 1, then 250 mg days 2-5, or 500 mg daily for 3 days) 2, 3
- Amoxicillin-clavulanate: 7-10 days 1, 2
- Clarithromycin: 7-10 days 7, 4
Critical Pitfalls to Avoid
- Do NOT prescribe antibiotics for acute bronchitis in healthy adults without clear bacterial indicators—this is the most common error 1, 2
- Do NOT assume purulent sputum indicates bacterial infection—sputum color alone is not diagnostic 2
- Do NOT use fluoroquinolones inactive against pneumococci (ciprofloxacin, ofloxacin) or cefixime 2
- Do NOT use cotrimoxazole due to inconsistent pneumococcal activity and poor benefit/risk ratio 1, 2
- Do NOT use aminopenicillins alone, first-generation cephalosporins, or macrolides as monotherapy in areas with high resistance rates 1
- Always distinguish bronchitis from pneumonia, which requires chest imaging and different management 2
Clinical Decision Algorithm
- Assess patient category: Healthy adult vs. chronic obstructive bronchitis vs. chronic respiratory insufficiency
- If healthy adult with acute bronchitis: Do NOT prescribe antibiotics 1, 2
- If chronic bronchitis: Count Anthonisen criteria—need ≥2 of 3 to justify antibiotics 1, 2
- If chronic respiratory insufficiency (FEV1 <35%): Start immediate antibiotic therapy 2
- Check for fever persistence: If >38°C for >3 days, consider bacterial superinfection 1, 2
- Associated ENT symptoms (rhinorrhea, nasal obstruction) suggest viral etiology—avoid antibiotics 1, 2